SHELTER PHARMA LIMITED

SHELTER

Small Cap | Pharmaceuticals
40.1
-1.74 (-4.15%)

Stock price as on 06 Feb 2026 at 15:23 PM

Shelter pharma limited share price update

As of the latest trading session, Shelter Pharma Limited share price is currently at ₹40.1, which is down by ₹-1.74 from its previous closing. Today t...

Shelter Pharma Limited stock performance

Today’s low

₹40.1

Today’s high

₹40.1

₹40.1

52 week low

₹30.21

52 week high

₹55.8

₹40.1
Open
₹40.10
Previous close
₹41.84
Share volume
3,000
Total traded value (Lakh)
₹1.20
Upper circuit
₹50.20
Lower circuit
₹33.48

Shelter Pharma Limited fundamentals

Market cap (Cr)
₹65.50
P/E ratio (TTM)
9.44
Book value per share
₹35.69
Beta
1.02
Return on equity
18.89%
Earnings per share (TTM)
₹4.43
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Shelter Pharma Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹50.66

Operating expense

₹40.99

Net income

₹7.24

Net profit margin

14.29%

Earning per share

₹6.26

EBITDA

₹10.08

Effective tax rate

25.2%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹40.02

Operating expense

₹31.75

Net income

₹6.20

Net profit margin

15.49%

Earning per share

₹5.36

EBITDA

₹8.58

Effective tax rate

25.12%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹36.15

Operating expense

₹28.27

Net income

₹5.21

Net profit margin

14.41%

Earning per share

₹6.72

EBITDA

₹7.15

Effective tax rate

25.5%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹30.06

Operating expense

₹27.56

Net income

₹1.84

Net profit margin

6.12%

Earning per share

₹37.96

EBITDA

₹2.68

Effective tax rate

26.69%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹22.48

Operating expense

₹22.73

Net income

-₹0.24

Net profit margin

-1.06%

Earning per share

-₹5.08

EBITDA

-₹0.12

Effective tax rate

-

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹36.14

Return on Equity (ROE)

18.89%

Return on Capital Employed (ROCE)

25.03%

Total debt to equity ratio

0.02

EBITDA margin

19.9%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹30.17

Return on Equity (ROE)

25.58%

Return on Capital Employed (ROCE)

33.54%

Total debt to equity ratio

0.05

EBITDA margin

21.96%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹17.57

Return on Equity (ROE)

55.27%

Return on Capital Employed (ROCE)

68.12%

Total debt to equity ratio

0.09

EBITDA margin

22.54%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹162.45

Return on Equity (ROE)

29.37%

Return on Capital Employed (ROCE)

40.45%

Total debt to equity ratio

0.01

EBITDA margin

10.15%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹127.48

Return on Equity (ROE)

0.66%

Return on Capital Employed (ROCE)

1.28%

Total debt to equity ratio

0.02

EBITDA margin

0.89%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹3.41

Total assets

₹48.33

Total liabilities

₹48.33

Total equity

₹42.72

Shares outstanding

₹1.15

Price to book ratio

₹1.00

Return on assets (%)

14.97%

Return on capital

16.54%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹5.03

Total assets

₹37.91

Total liabilities

₹37.91

Total equity

₹35.81

Shares outstanding

₹1.15

Price to book ratio

₹1.63

Return on assets (%)

16.35%

Return on capital

17.04%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.42

Total assets

₹21.44

Total liabilities

₹21.44

Total equity

₹14.54

Shares outstanding

₹0.77

Price to book ratio

-

Return on assets (%)

24.27%

Return on capital

31.87%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.10

Total assets

₹12.83

Total liabilities

₹12.83

Total equity

₹8.80

Shares outstanding

₹0.04

Price to book ratio

-

Return on assets (%)

16.03%

Return on capital

23.04%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.37

Total assets

₹10.20

Total liabilities

₹10.20

Total equity

₹7.11

Shares outstanding

₹0.04

Price to book ratio

-

Return on assets (%)

0.4%

Return on capital

0.58%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹9.67

Cash from operations

₹7.91

Cash from investing

-₹7.12

Cash from financing

₹0.02

Net change in cash

-₹1.61

Free cash flow

₹10.56

Particulars

Mar 24 (₹ value in crores)

Net income

₹8.28

Cash from operations

-₹0.40

Cash from investing

-₹4.54

Cash from financing

₹11.00

Net change in cash

₹4.49

Free cash flow

₹0.44

Particulars

Mar 23 (₹ value in crores)

Net income

₹7.88

Cash from operations

-

Cash from investing

₹0.11

Cash from financing

₹0.21

Net change in cash

₹0.32

Free cash flow

-

Particulars

Mar 22 (₹ value in crores)

Net income

₹2.80

Cash from operations

₹0.51

Cash from investing

-₹0.85

Cash from financing

₹0.06

Net change in cash

-₹0.27

Free cash flow

₹1.12

Particulars

Mar 21 (₹ value in crores)

Net income

₹0.06

Cash from operations

-₹0.28

Cash from investing

₹0.03

Cash from financing

₹0.48

Net change in cash

₹0.23

Free cash flow

-₹0.27

Shelter Pharma Limited technical summary

₹40.1
-4.15 ▼
8
Bearish
8
Bullish
5 Day41.7
10 Day40.4
12 Day40
20 Day39
26 Day38.7
50 Day38.8
100 Day40.1
200 Day42.4
5 Day42.2
10 Day40.4
12 Day39.4
20 Day37.5
26 Day37.4
50 Day38.2
100 Day41.1
200 Day41.2

42.35

PIVOT

First support
₹40.79
First resistance
₹43.39
Second support
₹39.75
Second resistance
₹44.95
Third support
₹38.19
Third resistance
₹45.99
RSI
62.66
ADX
20.76
MACD
1.33
Williams % R
-15.97
Commodity Channel Index (CCI)
112.64
Date
05 Feb 2026
Same day
18,000
Week
30,000
Month
38,053
1 year
1.02
3 years
0.8
Over 1 month
17.56%
Over 1 year
-19.69%
Over 3 months
2.44%
Over 3 years
-0.09%
Over 6 months
-3.43%
Over 6 years
0%

Investment Returns

Over 1 Month17.56%
Over 3 Months2.44%
Over 6 Months3.43%
Over 1 Year19.69%

Shelter Pharma Limited Shareholding pattern


Public
52.81%
Promoter holdings
47.18%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Shakil Nisarahmed Sabugar

22,10,000 (13.53%)

Shareholding of Promoter and Promoter Group

Mustaqim Nisarahmed Sabugar

17,44,000 (10.68%)

Shareholding of Promoter and Promoter Group

Zubedabibi Nisarahmed Sabugar

12,18,000 (7.46%)

Shareholding of Promoter and Promoter Group

Dr.nusrat Mustakim Sabugar

11,02,000 (6.75%)

Shareholding of Promoter and Promoter Group

Suraiya M Sakil Sabugar

11,02,000 (6.75%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Shakil Nisarahmed Sabugar22,10,000 (13.53%)Shareholding of Promoter and Promoter Group
Mustaqim Nisarahmed Sabugar17,44,000 (10.68%)Shareholding of Promoter and Promoter Group
Zubedabibi Nisarahmed Sabugar12,18,000 (7.46%)Shareholding of Promoter and Promoter Group
Dr.nusrat Mustakim Sabugar11,02,000 (6.75%)Shareholding of Promoter and Promoter Group
Suraiya M Sakil Sabugar11,02,000 (6.75%)Shareholding of Promoter and Promoter Group
Rifat Misbah Panchbhai5,01,000 (3.07%)Public Shareholding
Misbahul Mohmed Panchbhai5,01,000 (3.07%)Public Shareholding
Parvezbanu Mohamed Rafiq Idariya3,31,000 (2.03%)Shareholding of Promoter and Promoter Group
Rishabh Nayanbhai Sharma2,01,000 (1.23%)Public Shareholding
Shaikh Shabnam Mohammedrafiq1,80,000 (1.1%)Public Shareholding

About SHELTER PHARMA LIMITED

Shelter Pharma Limited originally named as 'Shelter Pharmacy', was converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company under the name 'Shelter Pharma Limited' on 12 October, 2007 with the Registrar of Companies, Gujarat. Company primarily focus in manufacturing of ayurvedic and herbal products with well-built presence in Human Pharma as well as Veterinary space. The Company was founded in 1965 by Mr. N. R. Gandhi, a well-known practitioner of Ayurveda and Unani healthcare systems. Introduction of new generatio

Parent Organisation

Indian Private

NSE Symbol

SHELTER PHARMA LIMITED

Founded

2007

SHELTER PHARMA LIMITED CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
23 Sept 20250.35Final23 Sept 2025Equity shares
23 Sept 20240.33Final23 Sept 2024Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)